https://ir.sutrobio.com/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/_dafa486b77118821db42bc1a953af823/sutrobio/files/theme/images/logo-sm.jpg Equisolve Investor Relations Suite https://ir.sutrobio.com/press-releases/detail/231/sutro-biopharma-reports-full-year-2025-financial-results-and-business-highlights Mon, 23 Mar 26 16:05:00 -0400 https://ir.sutrobio.com/press-releases/detail/231/sutro-biopharma-reports-full-year-2025-financial-results-and-business-highlights https://ir.sutrobio.com/press-releases/detail/230/sutro-biopharma-to-participate-in-upcoming-investor-conferences Wed, 25 Feb 26 08:30:00 -0500 https://ir.sutrobio.com/press-releases/detail/230/sutro-biopharma-to-participate-in-upcoming-investor-conferences https://ir.sutrobio.com/press-releases/detail/229/sutro-biopharma-announces-participation-at-the-16th-world-adc-london-summit Mon, 23 Feb 26 08:30:00 -0500 https://ir.sutrobio.com/press-releases/detail/229/sutro-biopharma-announces-participation-at-the-16th-world-adc-london-summit https://ir.sutrobio.com/press-releases/detail/228/sutro-biopharma-announces-pricing-of-110-0-million-underwritten-offering Tue, 10 Feb 26 07:00:00 -0500 https://ir.sutrobio.com/press-releases/detail/228/sutro-biopharma-announces-pricing-of-110-0-million-underwritten-offering https://ir.sutrobio.com/press-releases/detail/227/sutro-biopharma-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference Wed, 07 Jan 26 16:05:00 -0500 https://ir.sutrobio.com/press-releases/detail/227/sutro-biopharma-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference https://ir.sutrobio.com/press-releases/detail/226/sutro-biopharma-regains-compliance-with-nasdaq-minimum-bid-price-requirement Wed, 17 Dec 25 16:05:00 -0500 https://ir.sutrobio.com/press-releases/detail/226/sutro-biopharma-regains-compliance-with-nasdaq-minimum-bid-price-requirement https://ir.sutrobio.com/press-releases/detail/225/sutro-biopharma-announces-inducement-grants-under-nasdaq-listing-rule-5635c4 Tue, 16 Dec 25 16:05:00 -0500 https://ir.sutrobio.com/press-releases/detail/225/sutro-biopharma-announces-inducement-grants-under-nasdaq-listing-rule-5635c4 https://ir.sutrobio.com/press-releases/detail/224/sutro-biopharma-announces-first-cohort-of-patients-dosed-in-phase-1-trial-of-stro-004-a-next-generation-tissue-factor-adc-in-tf-expressing-solid-tumors Wed, 03 Dec 25 08:00:00 -0500 https://ir.sutrobio.com/press-releases/detail/224/sutro-biopharma-announces-first-cohort-of-patients-dosed-in-phase-1-trial-of-stro-004-a-next-generation-tissue-factor-adc-in-tf-expressing-solid-tumors https://ir.sutrobio.com/press-releases/detail/223/sutro-biopharma-announces-1-for-10-reverse-stock-split Mon, 01 Dec 25 08:00:00 -0500 https://ir.sutrobio.com/press-releases/detail/223/sutro-biopharma-announces-1-for-10-reverse-stock-split https://ir.sutrobio.com/press-releases/detail/222/sutro-biopharma-highlights-next-generation-adc-innovation-at-virtual-rd-day Wed, 12 Nov 25 10:00:00 -0500 https://ir.sutrobio.com/press-releases/detail/222/sutro-biopharma-highlights-next-generation-adc-innovation-at-virtual-rd-day